IITRI offers a wide range of bioanalytical services for the detection and quantification of both small molecule and biologic drug candidates from human clinical trial samples. Two recent publications highlight our experience in determining drug and hormone concentrations from human clinical trial samples of plasma, breast tissue, and nipple aspirate fluid (NAF).
Publications
Methodological considerations in estrogen assays of breast fluid and tissue
Related News
Breast-cancer drug has a surprising new application, study finds
Recent Comments